Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer

Authors

Keywords

Journal

Volume 27, Issue 3, Pages 337-342

Publisher

Springer Nature

Online

2009-02-13

DOI

10.1007/s00345-009-0382-4

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started